Abstract
The most important radioisotope for use in Nuclear Medicine is 99mTc, supplied in the form of a 99Mo/99mTc generator. After the supply crisis of 99Mo starting in 2008 the availability of 99Mo became a worldwide concern. The purpose of this work is to do a brief story of the availability of 99Mo in the world followed by an overview of the production routes of 99Mo and the generators technology.
Keywords: Fission of 235U, Molybdenum-99, Nuclear Reactor, Particle Accelerator, Radioisotope generator, Technetium-99m, HEU, LEU, GTRI/DOE efforts
Current Radiopharmaceuticals
Title:Technetium-99m – New Production and Processing Strategies to Provide Adequate Levels for SPECT Imaging
Volume: 5 Issue: 3
Author(s): J. A. Osso, M. F. Catanoso, G. Barrio, T. P. Brambilla, R. Teodoro, C. R. B. R. Dias and K. N. Suzuki
Affiliation:
Keywords: Fission of 235U, Molybdenum-99, Nuclear Reactor, Particle Accelerator, Radioisotope generator, Technetium-99m, HEU, LEU, GTRI/DOE efforts
Abstract: The most important radioisotope for use in Nuclear Medicine is 99mTc, supplied in the form of a 99Mo/99mTc generator. After the supply crisis of 99Mo starting in 2008 the availability of 99Mo became a worldwide concern. The purpose of this work is to do a brief story of the availability of 99Mo in the world followed by an overview of the production routes of 99Mo and the generators technology.
Export Options
About this article
Cite this article as:
A. Osso J., F. Catanoso M., Barrio G., P. Brambilla T., Teodoro R., R. B. R. Dias C. and N. Suzuki K., Technetium-99m – New Production and Processing Strategies to Provide Adequate Levels for SPECT Imaging, Current Radiopharmaceuticals 2012; 5 (3) . https://dx.doi.org/10.2174/1874471011205030178
DOI https://dx.doi.org/10.2174/1874471011205030178 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
Anti-Cancer Agents in Medicinal Chemistry Ultrasound Contrast Imaging in Cancer –Technical Aspects and Prospects
Current Molecular Imaging (Discontinued) Respiration and Energy Homeostasis
Current Respiratory Medicine Reviews Purinergic Signalling: What is Missing and Needed Next? The Use of Transgenic Mice, Crystallographic Analysis and MicroRNA
CNS & Neurological Disorders - Drug Targets Recent Clinical Trials of mTOR-Targeted Cancer Therapies
Reviews on Recent Clinical Trials The Functions of Histone Modification Enzymes in Cancer
Current Protein & Peptide Science Cancer Risk and Nullity of Glutathione-S-Transferase Mu and Theta 1 in Occupational Pesticide Workers
Current Pharmaceutical Biotechnology The Ca2+-Activated K+ Channel of Intermediate Conductance:A Molecular Target for Novel Treatments?
Current Drug Targets Ribonucleases, Nucleases and Antiangiogenins in Antiproliferative Activities
Current Signal Transduction Therapy Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Anticancer Properties of Flavonoids: Roles in Various Stages of Carcinogenesis
Cardiovascular & Hematological Agents in Medicinal Chemistry Will Medicinal Cannabinoids Prove to be Useful Clinically?
Current Drug Therapy Pharmacological Modulation of Nitric Oxide Release: New Pharmacological Perspectives, Potential Benefits and Risks
Current Medicinal Chemistry The Function of the Selective Inhibitors of Cycloxygenase 2
Mini-Reviews in Medicinal Chemistry Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Inhibitors of ABL and the ABL-T315I Mutation
Current Topics in Medicinal Chemistry Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases
Current Drug Safety Human Cancer Cell Line Based Approach of 1,3,4-thiadiazole and its Fused Ring: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?
Current Pharmacogenomics Radix Stephaniae Tetrandrine: An Emerging Role for Management of Breast Cancer
Current Pharmaceutical Design